Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Monthly Archives: April 2010
Therasense To Be Re-Heard En Banc – “I Feel Your Pain”
Monday’s decision by the Federal Circuit to vacate the split panel decision in Therasense, Inc. v. Becton Dickinson & Co., 593 F.3d 1289 (Fed. Cir. 2010) (link at end of post) and rehear the case en banc makes it impossible for … Continue reading
Breaking News: Teeth Chatter In Hell – Vatican Funds To Support Stem Cell Research!
The Vatican and the University of Maryland School of Medicine recently announced that the Vatican will contribute about $3M to fund research on stem cells derived from adult intestinal tissue. The funds will be used to support research at the … Continue reading
Stem Cell Patents Webinar and BIO Int’l Convention Symposium
Patent Claims Coverage Webinar: Stem Cell Industry – Osiris Therapeutics – Amgen’s EPO – Wed., April 28, 12:00PM – 12:50PM CDT Sunlight Research™ invites you to attend a Stem Cell Industry Patent Claims Coverage webinar presented by Robin A. Chadwick, … Continue reading
The Return Of The Magnificent Prosecution Specialists Or Just More “QA”?
The USPTO recently announced the creation of an ombudsman program to resolve applicant/examiner logjams in all of the Tech Centers. This is a move that the Office (and practitioners) have needed badly for a number of years, ever since the … Continue reading
Posted in USPTO Practice and Policy
Tagged biotechnology law, intellectual property, ip, Patent Law, USPTO, Warren Woessner
Leave a comment